Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acid-sensing ion channel 1 (ASIC1) is a neuronally expressed, proton-gated cation channel belonging to the epithelial sodium channel/degenerin (ENaC/DEG) superfamily[1][3]. It forms trimers that open in response to drops in extracellular pH by directly sensing protons via a specialized extracellular domain called the acidic pocket[4]. ASIC1 is highly permeable to sodium ions, with the ASIC1a isoform also allowing low-level calcium entry[1][2]. Rapid activation of ASIC1 (particularly ASIC1a) leads to transient neuronal excitation and is critically involved in diverse physiological processes such as synaptic plasticity, pain sensation, and learning and memory[3]. Pathologically, excessive activation of ASIC1 during tissue acidosis mediates cell death and contributes to ischemic brain injury, neurodegeneration, pain, and possibly psychiatric conditions[1][3]. Several small-molecule inhibitors and venom-derived peptide toxins (such as PcTx1) modulate ASIC1 activity and form the basis for potential drug development targeting neurological and pain disorders[4][5]. However, due to its fundamental role in central nervous system signaling, therapeutic targeting requires cell and context specificity to avoid undesired neurophysiological effects[3].
Inhibition of ion conductance (blockade of sodium and/or calcium entry through the channel) Allosteric modulation resulting in conformational stabilization of the closed/desensitized state Competitive antagonism at proton-binding or toxin-binding sites
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acid-sensing ion channel 1 (ASIC1).